Lumizyme
Active Ingredient(s): Alglucosidase AlfaFDA Approved: * May 24, 2010
Pharm Company: * GENZYME
Category: Enzymes
Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD).[4] Chemically speaking, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.[2] It was approved for medical use in the United... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Lumizyme 5 mg/ml Intravenous Injection, Powder, for Solution
NDC: 58468-0160
Labeler:
Genzyme Corporation